Technology offers

The OTT-SSPA offers the access service to all the technologies developed by the Andalusian Public Healthcare System, including patents, utility models, know-how and software. This space features all the technologies available in our Catalogue of Technology Offers We include over 50 new offers every year. If you cannot find what you are looking for, you can contact us here.

INFUSION LINE ANTI-OUTLET CONNECTOR
A research group of the Andalusian Public Health System in collaboration with the University of Seville, has developed a device that allows the infusion and administration of fluids, serums and intravenous medications comfortably, avoiding the risk of leaving the routes when the patient moves the hand or arm
ENDOSCOPIC FLUID APPLICATION DEVICE
A research group from the Andalusian Public Health System in collaboration with the University of Seville, has developed an endoscopic device designed to apply a fluid in a confined area within the surgical field.
ADVANCED SIMULATION PLATFORM FOR TRAINING THE SELECTIVE BIOPSY OF THE INGUINAL SENTINEL NODE
A research group of the Andalusian Public Health System in collaboration with the Polytechnic University of Catalonia, has developed an advanced simulation platform that allows the correct initial learning and training of the selective biopsy of the inguinal sentinel lymph node prior to human practice.
FUSCLEAN: NON-INVASIVE CLEANING OF CEREBROSPINAL LIQUID IN HYDROCEPHALUS PATIENTS
A research group of the Andalusian Public Health System in collaboration with the University of Seville, has developed a pre-prototype non-invasive cleaning device of cerebrospinal liquid in hydrocephalus patients
NEURAL STEM CELLS FROM CEREBROSPINAL FLUID OF PREMATURE BABIES WITH INTRAVENTRICULAR HAEMORRHAGE
A research group from Andalusian Public Health System, in collaboration with the University of Malaga, has isolated neural stem cells (NSCs) from the cerebrospinal fluid (CSF) of preterm infants with intraventricular haemorrhage (IVH) suitable as advanced therapy for the autologous treatment of infants with IVH or for developing allogeneic therapies for different neurological disorders.
KIT TO PREDICT AND / OR PREDICT THE RESPONSE TO A TREATMENT WITH FGFR INHIBITORS
A research group of the Andalusian Public Health System in collaboration with the Hospital 12 de Octubre de Madrid and the CSIC, has developed an in vitro method and kit to predict the response of a subject suffering from lung cancer to treatment with inhibitors of FGFR.
LACTOPEROXIDASE AS PARKINSON BIOMARKER
A research group from the Andalusian Health System and Sevilla University has developed a new method for the diagnosis of Parkinson.
NANOSTRUCTURES FOR THE DIAGNOSIS OF ALLERGIES TO BETALACTAMIC ANTIBIOTICS
A research group from the Biomedical Research Institute of Málaga (IBIMA) has developed a new method for the diagnosis of amoxicillin-mediated allergic reactions using nanostructures.
BIOMARKERS TO PREDICT RESPONSE TO TREATMENT IN METASTATIC MELANOMA PATIENTS
A research group from the Biomedical Research Institute of Málaga (IBIMA) has developed a new biomarker panel to predict response to treatment in metastatic melanoma patients.
HIGHLY INDUCIBLE TET-ON VECTOR SYSTEM
A research group from the Andalusian Public Health System (SSPA) has developed a TetR(Tetracycline repressor)-based all-in-one lentiviral system

Pages